L-Pampo™, a Novel TLR2/3 Agonist, Acts as a Potent Cancer Vaccine Adjuvant by Activating Draining Lymph Node Dendritic Cells

SIMPLE SUMMARY: Toll-like receptor (TLR) agonists induce strong immune responses, which are used as an effective adjuvant system for vaccine development. L-pampo™ is our innovative adjuvant system containing TLR2 and TLR3 agonists, and it provides robust humoral and cellular immune responses against...

Descripción completa

Detalles Bibliográficos
Autores principales: Heo, Yoonki, Ko, Eunbyeol, Park, Sejung, Park, Si-On, Ahn, Byung-Cheol, Yum, Jung-Sun, Chun, Eunyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417701/
https://www.ncbi.nlm.nih.gov/pubmed/37568794
http://dx.doi.org/10.3390/cancers15153978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417701/
https://www.ncbi.nlm.nih.gov/pubmed/37568794
http://dx.doi.org/10.3390/cancers15153978

Ejemplares similares